financetom
Business
financetom
/
Business
/
Novartis Says Pluvicto Shows Benefit in Early Prostate Cancer Study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Novartis Says Pluvicto Shows Benefit in Early Prostate Cancer Study
Jun 2, 2025 3:14 AM

05:59 AM EDT, 06/02/2025 (MT Newswires) -- Novartis ( NVS ) said Monday that its radioligand therapy, Pluvicto, combined with standard care, significantly improved radiographic progression-free survival in a pre-specified interim analysis of a phase 3 trial for patients with a certain type of prostate cancer.

The drugmaker said a positive trend in overall survival was also observed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Citi managing director details 'pervasive' sexual harassment in lawsuit
Citi managing director details 'pervasive' sexual harassment in lawsuit
Apr 22, 2024
NEW YORK, April 22 (Reuters) - A Citigroup ( C/PN ) managing director said the bank failed to protect her from a supervisor's violent threats and abuse because of its pervasive culture of sexual harassment and gender discrimination, according to an amended legal filing on Monday. Ardith Lindsey, who worked as Americas head of electronic sales trading, added details to...
What's Going On With Tesla Stock Monday?
What's Going On With Tesla Stock Monday?
Apr 22, 2024
Tesla Inc ( TSLA ) shares are trading lower Monday after the company reduced vehicle prices in the U.S., Germany and China. What Happened: After the market close on Friday, Tesla introduced a fresh round of price cuts in the United States. The company cut the prices of its Model Y, Model X and Model S vehicles by $2,000. On...
Informatica says it is not in any acquisition talks, updates forecast
Informatica says it is not in any acquisition talks, updates forecast
Apr 22, 2024
April 22 (Reuters) - Data-management software firm Informatica ( INFA ) is not currently engaged in any discussions to be acquired, the company said on Monday, after media reports of takeover interest from Salesforce ( CRM ). Shares of Informatica ( INFA ) were down more than 5% in early trading. Salesforce ( CRM ) backed way from its talks...
LuxUrban Hotels Names Elan Blutinger as Nonexecutive Chairman; Shares Rise
LuxUrban Hotels Names Elan Blutinger as Nonexecutive Chairman; Shares Rise
Apr 22, 2024
09:35 AM EDT, 04/22/2024 (MT Newswires) -- LuxUrban Hotels ( LUXH ) said Monday that Elan Blutinger has been named nonexecutive chairman of the board, effective immediately. Blutinger, who joined the company's board in February, succeeds Brian Ferdinand, the company's founder, former chief executive and biggest shareholder, LuxUrban said. Separately, LuxUrban said that Andrew Schwartz has been named to the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved